Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

February 2027 74

  1. Primary completion Surface-Modified Flow Diverter for Intracranial Aneurysms: Assessment of Ischemic and Clinical Outcomes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07674004

March 2027 99

  1. Primary completion Colchicine Use for Primary Prevention of Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05175274

  2. Primary completion STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05785897

  3. Study completion Antagonization of Heparin With Protamine Sulfate After TAVI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06215378

  4. Primary completion Antagonization of Heparin With Protamine Sulfate After TAVI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06215378

  5. Primary completion International Care Bundle Evaluation in Cerebral Hemorrhage Research Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06429332

  6. Study completion Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06751459

  7. Study completion SIRAKI 02 Posthoc Analysis. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06781294

  8. Primary completion Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07002476

  9. Primary completion Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07113184

  10. Primary completion Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07173855

  11. Primary completion A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07654140

  12. Study start Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07683923

  13. Study start Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07698223

  14. Study completion Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03789552

  15. Primary completion Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04591392

  16. Study completion Pre- Vs Postoperative Thromboprophylaxis for Liver Resection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04731558

  17. Study completion THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05194423

  18. Primary completion THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05194423

  19. Study completion Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05305612

  20. Study completion CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05681351

  21. Primary completion CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05681351

  22. Primary completion Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05769868

  23. Study completion Colchicine After Electrocardioversion for Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05890664

  24. Primary completion Colchicine After Electrocardioversion for Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05890664

  25. Study completion Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06271577

  26. Study completion Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06359782

  27. Primary completion Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06359782

  28. Primary completion Closed-loop in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06579404

  29. Primary completion ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06611319

  30. Study completion Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07060456

  31. Primary completion Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07113223

  32. Primary completion BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07118358

  33. Primary completion A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07142356

  34. Study completion A Study to Evaluate the Safety and Effectiveness of the FastWave Artero™ Peripheral Intravascular Lithotripsy (IVL) System in Adults With Peripheral Artery Disease (PAD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07209085

  35. Primary completion A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07215559

  36. Study completion Epicardial Cardiac Fat-CT (EPIC-CT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07297589

  37. Primary completion A Study of SHR-1918 In Participants With Hypertriglyceridemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07349615

  38. Primary completion Effect of Add-on L-Arginine Therapy on Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07394270

  39. Study completion QLS1410 in Participants With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07489612

  40. Primary completion Neurophysiological Markers for Prediction of Rehabilitation Outcomes After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07520630

  41. Primary completion Using Mobile Stress Management to Reduce Hypertension in African American Men Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07594808

  42. Study completion Management of Iron Deficiency Anemia in Hemodialysis Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07706582

  43. Study completion A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07724340

  44. Study completion Non-Invasive Triage for Intracranial Hypertension in Prehospital Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07747636

  45. Study completion Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07801820

  46. Primary completion Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07801820

  47. Study completion RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07889388

  48. Primary completion RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07889388

  49. Study completion Aggressive Smoking Cessation Trial (ASAP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05257629

  50. Study start The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06953778

  51. Study completion Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06835491

  52. Study completion Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07129421

  53. Study completion Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05879276

  54. Primary completion Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05879276

  55. Primary completion The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06606821

  56. Study completion Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07579702

  57. Primary completion Post-Stroke Secondary Prevention With Digital Monitoring Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06837311

  58. Primary completion Relevance of Recording an ECG Trace With a Connected Watch Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06272396

  59. Primary completion Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05591118

  60. Primary completion CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05726526

  61. Study completion The Renal Protective Effects of Remote Ischemic Preconditioning in Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06501222

  62. Study completion Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06660719

  63. Primary completion Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06660719

  64. Primary completion Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06743659

  65. Study completion Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06765356

  66. Primary completion Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06765356

  67. Primary completion Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07047014

  68. Primary completion A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07156500

  69. Primary completion A Phase 3 Study of HS-20094 in Patients With T2DM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07156539

  70. Study completion Design and Application of a Home Care WeChat Mini-Program for Children After Congenital Heart Disease Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07385209

  71. Primary completion Effectiveness of Supervised and Unsupervised mHealth-based Exercise Interventions on Clinical Outcomes in Adults With Type 2 Diabetes and Obesity Within a Primary Care Context Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07685080

  72. Study completion TeleStroke-Guided Thrombolysis for Acute Ischemic Stroke in Oman Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07721129

  73. Primary completion The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03129555

  74. Study completion Sit Less, Interact and Move More (SLIMM) 2 Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05173714

  75. Study completion Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05366868

  76. Primary completion SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05583773

  77. Study completion NAD Augmentation in Diabetes Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05759468

  78. Study completion The Impact of Expandable Cryoballoon on Autonomic Control of the Heart Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06053606

  79. Primary completion The Impact of Expandable Cryoballoon on Autonomic Control of the Heart Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06053606

  80. Primary completion The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06059664

  81. Primary completion Pivotal Trial of the Boomerang Catheter for pDVA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06311773

  82. Primary completion THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06559891

  83. Primary completion Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant PFA Balloon for the Treatment of AF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06828939

  84. Study completion RADIQAL Study (Radiation Dose and Image Quality Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06944509

  85. Primary completion RADIQAL Study (Radiation Dose and Image Quality Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06944509

  86. Study completion Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07109739

  87. Primary completion Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07109739

  88. Study completion Glycemic Variability of Combination Therapies in T2DM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07442006

  89. Primary completion Glycemic Variability of Combination Therapies in T2DM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07442006

  90. Study completion Furosemide vs Placebo in Severe Preeclampsia Postpartum Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07648251

  91. Primary completion Furosemide vs Placebo in Severe Preeclampsia Postpartum Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07648251

  92. Primary completion Cryoablation for Monomorphic Ventricular Tachycardia (VTS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07650032

  93. Study completion Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07800572

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Standard Care Versus Triventricular Pacing in Heart Failure Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02529410

  2. Primary completion Cytokine Adsorption in Sepsis and Acute Kidney Injury Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02588794

  3. Study completion Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02627521

  4. Primary completion Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02627521

  5. Study completion Quantitation of Left Ventricular Ejection Fraction Change From Early Exercise Gated Stress/Rest Tc-99m CZT-SPECT MPI Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02863952

  6. Primary completion Quantitation of Left Ventricular Ejection Fraction Change From Early Exercise Gated Stress/Rest Tc-99m CZT-SPECT MPI Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02863952

  7. Study completion The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02870764

  8. Primary completion Randomized Controlled Trial of Renal Denervation for Resistant Hypertension Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02900729

  9. Study start A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03082508

  10. Study start Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina. Registry record

    Expected 2017-08; that period ended on 2017-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03171597

  11. Study start Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI Registry record

    Expected 2017-09-01; that period ended on 2017-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03252665

  12. Study completion Comparative Study Between Cryoablation and Radiofrequency Ablation in the Treatment of Supraventricular Tachycardia Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01584154

  13. Primary completion Comparative Study Between Cryoablation and Radiofrequency Ablation in the Treatment of Supraventricular Tachycardia Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01584154

  14. Primary completion Mid-HDF Randomized Controlled Study on Outcome Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01693354

  15. Study completion Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02224209

  16. Primary completion Cyclosporine A in Patients With Small Diameter Abdominal Aortic Aneurysms Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02225756

  17. Primary completion NeoVas Bioresorbable Coronary Scaffold Registry Study Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02305472

  18. Study completion Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02313584

  19. Study completion Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02387450

  20. Primary completion Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS) Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02484027

  21. Primary completion High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02534155

  22. Primary completion SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02544204

  23. Primary completion The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02850627

  24. Study completion Quantitation of Cardiac Output Change by Impedance Cardiography in Subjects Undergoing Exercise Gated Stress/Rest Tc-99m CZT-SPECT MPI Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02863939

  25. Primary completion Quantitation of Cardiac Output Change by Impedance Cardiography in Subjects Undergoing Exercise Gated Stress/Rest Tc-99m CZT-SPECT MPI Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02863939

  26. Primary completion Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02894255

  27. Primary completion To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03089450

  28. Study start Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage Registry record

    Expected 2017-09; that period ended on 2017-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03271697

  29. Study start Low Dose Statins, Ezetimibe and Nutraceuticals Registry record

    Expected 2017-10-01; that period ended on 2017-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03277079

  30. Primary completion Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02174939

  31. Primary completion Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02549963

  32. Primary completion Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02583438

  33. Study completion Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02592694

  34. Primary completion Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02592694

  35. Study completion Cocktail Injection Improves Outcomes of FFR Guided PCI Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02592720

  36. Primary completion Cocktail Injection Improves Outcomes of FFR Guided PCI Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02592720

  37. Study completion Clinical and Microbiological Evaluation of Periodontal Treatment of Diabetic Patients: A Longitudinal Study Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02643771

  38. Primary completion Frailty and Cognitive Function Assessment of TAVI Patients Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02650388

  39. Study completion Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02791958

  40. Primary completion Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy Registry record

    Expected 2017-10; that period ended on 2017-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02791958

  41. Study completion Walking Estimated Limitation Calculated by History - Study 2 Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01424020

  42. Primary completion Walking Estimated Limitation Calculated by History - Study 2 Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01424020

  43. Study completion Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02284048

  44. Study completion Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02526875

  45. Primary completion Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02526875

  46. Study completion SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02544204

  47. Study completion Ezetimibe and Atorvastatin Therapy on TCFA Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02588235

  48. Primary completion Ezetimibe and Atorvastatin Therapy on TCFA Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02588235

  49. Study completion Thrombus Aspiration in Patients With STEMI Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02606435

  50. Primary completion Thrombus Aspiration in Patients With STEMI Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02606435

  51. Study start A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02641652

  52. Study start Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis Registry record

    Expected 2017-11; that period ended on 2017-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03342807

  53. Primary completion Recurrent Stroke Prevention Clinical Outcome Study Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01198496

  54. Study completion Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01385319

  55. Study completion Ranolazine Loading to Prevent PCI-induced Myocardial Injury Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01491061

  56. Study completion N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01491243

  57. Study completion Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION) Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01600235

  58. Primary completion Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION) Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01600235

  59. Study completion Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01638078

  60. Study completion PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01648829

  61. Study completion Nutraceuticals to Improve Lipid Profile in European Countries Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01649986

  62. Study completion Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01768208

  63. Study completion Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01807078

  64. Study completion Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01810796

  65. Primary completion The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01816997

  66. Study completion Rosuvastatin for Preventing Complications in Renal Ablation Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01899027

  67. Primary completion The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01942109

  68. Primary completion Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent Registry record

    Expected 2017-12-31; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02014818

  69. Primary completion The Safety and Efficacy of AVI Stent for Treating Coronary Revascularization Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02117843

  70. Primary completion Pyridorin in Diabetic Nephropathy Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02156843

  71. Primary completion Transcatheter Aortic Valve Replacement System Pivotal Trial Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02163850

  72. Study completion Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02169570

  73. Study completion Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02174939

  74. Study completion Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02224534

  75. Study completion Effects of MTS-r on Speech Production in Non-fluent Aphasia Post-ischemic Stroke Patients Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02241213

  76. Study completion Surgical Ablation of Long-standing Persistent AF During CABG Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02246790

  77. Study completion Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02264964

  78. Primary completion Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02264964

  79. Primary completion Xience Versus Synergy in Left Main PCI Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02303717

  80. Study completion Efficacy and Safety on Prouk for STEMI Patients in China Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02367976

  81. Study completion Prospective multicEntric NonranDomized Registry Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02496169

  82. Study completion Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02504437

  83. Primary completion Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02504437

  84. Study completion Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02509754

  85. Primary completion Subclinical Postoperative Atrial Fibrillation Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02522364

  86. Primary completion NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02557217

  87. Study completion Cytokine Adsorption in Sepsis and Acute Kidney Injury Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02588794

  88. Study completion Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02642419

  89. Primary completion Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02642419

  90. Study completion Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02646397

  91. Primary completion Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02646397

  92. Study completion Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02648126

  93. Primary completion The Fluid Therapy Strategy of the Non-dehydrated Patients With Acute Ischemic Stroke. Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02668848

  94. Primary completion Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo. Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02715687

  95. Study completion The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02850627

  96. Study completion MitraClip for Severe TR Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02863549

  97. Primary completion MitraClip for Severe TR Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02863549

  98. Study completion A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02877173

  99. Study completion Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02954029

  100. Study completion Using 3D Imaging to Optimize Bifurcation Stenting Registry record

    Expected 2017-12; that period ended on 2017-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02972489